Profound Medical Corp. (formerly Mira IV Acquisition Corp.)

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.7
Menawat, Dr., Arun Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
382.40
Quantity 5,619 +5.7%
Value US$4,963,840
Knudson, Ken Senior Officer of Issuer Officer
Transaction date
Purchase
Price
64.36
Quantity 22,924 +0.8%
Value US$2,027,080
Knudson, Ken Senior Officer of Issuer Officer
Transaction date
Purchase
Price
144.45
Quantity 98,118 +24.2%
Value US$2,899,012
2.5
Rosenthal, Arthur Lee Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
9.48
Quantity 538 +3.2%
Value US$5,102
2.5
Rosenthal, Arthur Lee Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
8.93
Quantity 3,000 +21.8%
Value US$26,786
2.5
Rosenthal, Arthur Lee Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
9.22
Quantity 500 +3.8%
Value US$4,610
2.5
Rosenthal, Arthur Lee Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
9.08
Quantity 6,762 +104.0%
Value US$61,426
2.7
Menawat, Dr., Arun Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
6.55
Quantity 1,000 +0.2%
Value US$6,550
2.7
Menawat, Dr., Arun Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
6.90
Quantity 2,500 +0.6%
Value US$17,250
Lortie, Murielle Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
8.62
Quantity 1,735 +122.6%
Value CA$14,956
Lavoie, Cynthia Ann Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
8.68
Quantity 2,400 +66.7%
Value CA$20,832
1.5
Dewan, Rashed Osman Senior Officer of Issuer Officer
Transaction date
Purchase
Price
8.95
Quantity 4,000 +40.0%
Value CA$35,800
Lavoie, Cynthia Ann Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
8.90
Quantity 600 +20.0%
Value CA$5,340
2.7
Menawat, Dr., Arun Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
6.92
Quantity 30,000 +7.9%
Value US$207,705
2.7
Menawat, Dr., Arun Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
6.65
Quantity 30,516 +8.8%
Value US$203,078
Knudson, Ken Senior Officer of Issuer Officer
Transaction date
Purchase
Price
7.07
Quantity 8,000 +190.5%
Value US$56,526
Ellacott, Brian Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
7.05
Quantity 50,000 +277.8%
Value US$352,500
Lavoie, Cynthia Ann Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
18.73
Quantity 3,000
Value CA$56,196
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2022-12-20 2022-12-20 B Purchase

Director of Issuer, Senior Officer of Issuer

Executive Director
5,619 +5.7%
382.40
US$4,963,840
5,619 +5.7% 382.40 US$4,963,840
2022-09-13 2022-09-07 B Purchase

Senior Officer of Issuer

Officer
22,924 +0.8%
64.36
US$2,027,080
22,924 +0.8% 64.36 US$2,027,080
2022-06-14 2022-06-14 B Purchase

Senior Officer of Issuer

Officer
98,118 +24.2%
144.45
US$2,899,012
98,118 +24.2% 144.45 US$2,899,012
2022-06-02 2022-06-02 B Purchase

Director of Issuer

Non-Executive Director
538 +3.2%
9.48
US$5,102
538 +3.2% 9.48 US$5,102
2022-06-02 2022-06-01 B Purchase

Director of Issuer

Non-Executive Director
3,000 +21.8%
8.93
US$26,786
3,000 +21.8% 8.93 US$26,786
2022-06-02 2022-06-01 B Purchase

Director of Issuer

Non-Executive Director
500 +3.8%
9.22
US$4,610
500 +3.8% 9.22 US$4,610
2022-06-02 2022-05-31 B Purchase

Director of Issuer

Non-Executive Director
6,762 +104.0%
9.08
US$61,426
6,762 +104.0% 9.08 US$61,426
2022-05-25 2022-05-24 B Purchase

Director of Issuer, Senior Officer of Issuer

Executive Director
1,000 +0.2%
6.55
US$6,550
1,000 +0.2% 6.55 US$6,550
2022-05-21 2022-05-20 B Purchase

Director of Issuer, Senior Officer of Issuer

Executive Director
2,500 +0.6%
6.90
US$17,250
2,500 +0.6% 6.90 US$17,250
2022-05-20 2022-05-20 B Purchase

Director of Issuer

Non-Executive Director
1,735 +122.6%
8.62
CA$14,956
1,735 +122.6% 8.62 CA$14,956
2022-05-20 2022-05-20 B Purchase

Director of Issuer

Non-Executive Director
2,400 +66.7%
8.68
CA$20,832
2,400 +66.7% 8.68 CA$20,832
2022-05-18 2022-05-18 B Purchase

Senior Officer of Issuer

Officer
4,000 +40.0%
8.95
CA$35,800
4,000 +40.0% 8.95 CA$35,800
2022-05-20 2022-05-13 B Purchase

Director of Issuer

Non-Executive Director
600 +20.0%
8.90
CA$5,340
600 +20.0% 8.90 CA$5,340
2022-05-16 2022-05-13 B Purchase

Director of Issuer, Senior Officer of Issuer

Executive Director
30,000 +7.9%
6.92
US$207,705
30,000 +7.9% 6.92 US$207,705
2022-05-13 2022-05-12 B Purchase

Director of Issuer, Senior Officer of Issuer

Executive Director
30,516 +8.8%
6.65
US$203,078
30,516 +8.8% 6.65 US$203,078
2022-05-13 2022-05-12 B Purchase

Senior Officer of Issuer

Officer
8,000 +190.5%
7.07
US$56,526
8,000 +190.5% 7.07 US$56,526
2022-05-12 2022-05-12 B Purchase

Director of Issuer

Non-Executive Director
50,000 +277.8%
7.05
US$352,500
50,000 +277.8% 7.05 US$352,500
2022-05-20 2021-05-20 B Purchase

Director of Issuer

Non-Executive Director
3,000
18.73
CA$56,196
3,000 18.73 CA$56,196
Explore more

More insider trading research around Profound Medical Corp. (formerly Mira IV Acquisition Corp.)